drugset / Trial / NCT04374994

Daily Avanafil for Erectile Dysfunction

NCT04374994

Phase 4 Completed 70 enrolled University of Alexandria
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study, the investigators tried to study the effect of daily avanafil on the serum level of endothelial function markers, as well as its impact on the erectile function in males with erectile and endothelial dysfunction by comparing the results with controls who received placebo.

Timeline

Start
2018-09-01
Primary completion
2019-04-15
Completion
2019-10-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Avanafil Small molecule 50 mg Oral

Indications